Hereditary Transthyretin Amyloidosis (hATTR) with Polyneuropathy / UK / £40 / Ends 28th March
This study is for the UK, aiming to understand the experiences of patients with Hereditary Transthyretin Amyloidosis (hATTR) with Polyneuropathy and to gather feedback on their journey.


Time & Location
12 Feb 2025, 13:00 GMT – 28 Mar 2025, 18:00 GMT
Zoom
Study objectives
This study is for the UK, aiming to understand the experiences of patients with Hereditary Transthyretin Amyloidosis (hATTR) with Polyneuropathy and to gather feedback on their journey.
The research will involve a 15-minute pre-task and 45 minute web-assisted telephone interview via an internet-based platform, where we would like to discuss your experiences and gather your insights.
A short screening process will be conducted to confirm eligibility.
As a token of our appreciation for your time, participants in the interview will receive:
£40 GBP